TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03421015 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT03421015 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT03421015 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT01997112 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02345317 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01281878 — Predictive Biomarker (PRD): PDXP mRNA
Genes: PDXP; CIN; PLP; PLPP
Study NCT01281878 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT00978926 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00978926 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00978926 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02453919 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00599131 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01765478 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT01765478 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT03353740 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02846220 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00898326 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT00898326 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT03570008 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00980161 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-122
Genes: MIR122
Study NCT00600392 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00004036 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00056706 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02111005 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT02111005 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT02111005 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT03302364 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT02135367 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT01666925 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study NCT03881761 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02482779 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03580330 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01027507 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01977716 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01977716 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT01243268 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00748852 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study NCT01624142 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00727441 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00796640 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT00796640 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00940667 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00701519 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01593150 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT01593150 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01593150 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00202592 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01890330 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT01890330 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT01890330 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02038348 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT00004328 — Surrogate Endpoint (SUR): Serum potassium
Study NCT00948220 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01289938 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01289938 — Safety Biomarker (SAF): DRD2
Study NCT00001144 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04580147 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04580147 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04416022 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT00480792 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00670787 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02625207 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT04988191 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT00358345 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03737526 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03215433 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01909791 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01909791 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03171675 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT04352426 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00985036 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00985036 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01809470 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03009682 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02234063 — Predictive Biomarker (PRD): APOL1 mRNA
Genes: APOL1; APOL
Study NCT01634256 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00192088 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT00192088 — Predictive Biomarker (PRD): DHFR mRNA
Genes: DHFR
Study NCT03607188 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03607188 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT00239031 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02087332 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01746251 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01549301 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00935883 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT03396328 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00227201 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00231140 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT00231140 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03593915 — Predictive Biomarker (PRD): PMAIP1 mRNA
Genes: PMAIP1; NOXA
Study NCT00357578 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03584204 — Safety Biomarker (SAF): Thiopurine S-methyltransferase
Genes: TPMT
Study NCT02093858 — Predictive Biomarker (PRD): TCF7L2 mRNA
Genes: TCF7L2; TCF4
Study NCT02093858 — Predictive Biomarker (PRD): SLC30A8 mRNA
Genes: SLC30A8; ZNT8
Study NCT00732602 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT03793400 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04269083 — Predictive Biomarker (PRD): BIRC3 mRNA
Genes: BIRC3; API2; MIHC; RNF49
Study NCT04321811 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02440932 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT02440932 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT02209025 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01942005 — Predictive Biomarker (PRD): TMC6 mRNA
Genes: TMC6; EVER1; EVIN1
Study NCT01942005 — Predictive Biomarker (PRD): TMC8 mRNA
Genes: TMC8; EVER2; EVIN2
Study NCT00753844 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04292431 — Predictive Biomarker (PRD): CPD mRNA
Genes: CPD
Study NCT03850093 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03161587 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT04647110 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT00975091 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03284918 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT00027833 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT00884767 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT04268134 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02064764 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00446914 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02102256 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT00079378 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT01835184 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04308031 — Predictive Biomarker (PRD): HCN4 mRNA
Genes: HCN4
Study NCT00395967 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00395967 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00001131 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00001131 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00594711 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study NCT03049449 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT03654911 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT04573179 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01724619 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT06105619 — Predictive Biomarker (PRD): PTPRZ1 mRNA
Genes: PTPRZ1; HTPZP2; PTPRZ; PTPRZ2; PTPZ
Study NCT06105619 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04543617 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT00575861 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02388295 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT04635605 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT03224949 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study NCT01728792 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04571983 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04571983 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT00747149 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03472313 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT01915524 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02802644 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00123461 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT02764203 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00941252 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02395172 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00607048 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT01911910 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00313781 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT02729493 — Predictive Biomarker (PRD): EPCAM mRNA
Genes: EPCAM; GA733-2; M1S2; M4S1; MIC18; TACSTD1; TROP1
Study NCT00928330 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05604716 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study NCT02126683 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT02126683 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02126683 — Safety Biomarker (SAF): Th2 cell
Study NCT01351987 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT01446250 — Predictive Biomarker (PRD): BOC mRNA
Genes: BOC; UNQ604/PRO1190
Study NCT00606671 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00579254 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04267640 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT01644903 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02575430 — Predictive Biomarker (PRD): RPE65 mRNA
Genes: RPE65
Study NCT02575430 — Predictive Biomarker (PRD): LRAT mRNA
Genes: LRAT
Study NCT01912352 — Predictive Biomarker (PRD): ADRA2A mRNA
Genes: ADRA2A; ADRA2R; ADRAR
Study NCT01912352 — Predictive Biomarker (PRD): SLC6A2 mRNA
Genes: SLC6A2; NAT1; NET1; SLC6A5
Study NCT03920969 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01058538 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04326101 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT04084223 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00131924 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01330901 — Safety Biomarker (SAF): Interleukin 12
Study NCT04677582 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04579549 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03062254 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03027791 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00933218 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00333944 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study NCT01090557 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT02489422 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02489422 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00228813 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04883723 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03534141 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT00201162 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00158132 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02081066 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study NCT02970682 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02970682 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02970682 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02145325 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02593071 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00436501 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00002952 — Safety Biomarker (SAF): Interleukin 12
Study NCT00002952 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03371355 — Predictive Biomarker (PRD): ANGPTL3 mRNA
Genes: ANGPTL3; ANGPT5; UNQ153/PRO179
Study NCT00558935 — Predictive Biomarker (PRD): ABCA1 mRNA
Genes: ABCA1; ABC1; CERP
Study NCT03262753 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02148783 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT01397721 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT02049125 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT03532568 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT01418261 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02265198 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT01493531 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT01354639 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03462251 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03462251 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT03462251 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00977470 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00977470 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04209231 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04209231 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04209231 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02965378 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT00787436 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03402230 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study NCT00336323 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04586426 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT03017521 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT03017521 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study NCT00807573 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02696928 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT00314483 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00986284 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00074698 — Predictive Biomarker (PRD): CCN2 mRNA
Genes: CCN2; CTGF; HCS24; IGFBP8
Study NCT00910624 — Predictive Biomarker (PRD): BOC mRNA
Genes: BOC; UNQ604/PRO1190
Study NCT00535340 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT02337231 — Predictive Biomarker (PRD): FADS1 mRNA
Genes: FADS1; FADSD5
Study NCT03925519 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02667353 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02667353 — Safety Biomarker (SAF): BDNF
Study NCT00982774 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study NCT00511420 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02516540 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02811835 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02624947 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03469869 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01219556 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05066555 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT01643031 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT00345644 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03458715 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02536248 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT03339895 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04203901 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study NCT02043886 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00681577 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT00681577 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT00681577 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT05799859 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT02694094 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02932410 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04486417 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01403506 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01403506 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT03885167 — Pharmacodynamic Biomarker (PDY): Ataxin-3
Genes: ATXN3; ATX3; MJD; MJD1; SCA3
Study NCT03542526 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04720950 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01046435 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01046435 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00043329 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05099224 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00450008 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03295903 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00594425 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT03573011 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27